BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Stefan Fischer Appointed CEO of Mutabilis


5/20/2008 7:01:00 AM

Parc de Biocitech, Romainville, May 20, 2008 – Mutabilis, www.mutabilis.com, a biopharma company specializing in the discovery and development of innovative anti-infective therapies, today announced that Stefan Fischer has joined the firm as Chief Executive Officer (CEO).

Prior to joining Mutabilis, Stefan Fischer acquired significant experience in the UK as CEO at Lorantis, where he efficiently led a wide-ranging corporate refocusing operation, and then at Capsant, where he managed the company's overall strategy and contributed to its excellent performance.

He had previously spent 10 years with Roche in Germany managing a number of product portfolios in the AIDS, cancer and obesity fields, before taking up a Market Analyst post where he coordinated the business and sales launches for a range of products on the German market. He then moved to the Licensing Department as Global Alliance Director, where he built and managed teams for assessing product in-licensing and acquisition opportunities.

Stefan Fischer holds an MSc in Chemistry from the University of Bochum.

"I am really looking forward to working with Stefan", emphasized Sonia Escaich, PhD., CSO and a Mutabilis co-founder. "In view of his international experience and his expertise in our business sector, Stefan has the perfect profile for giving new momentum to the company".

"I am delighted to be joining the Mutabilis team, which is widely acknowledged for its expertise and innovative approach in the field of antibiotic resistance – a major issue for the healthcare industry", commented Stefan Fischer, President of the Executive Board and CEO of Mutabilis.

Caroline Carmagnol ALIZE RP + 33 6 64 18 99 59



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES